Arcturus Therapeutics Stock (NASDAQ: ARCT) stock price, news, charts, stock research, profile.
Open | $20.88 |
Close | $20.61 |
Volume / Avg. | 572.78K / 489.94K |
Day Range | $20.39 - $21.50 |
52 Wk Range | 17.52 - 45.00 |
Market Cap | $557.34M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 50 |
Short Interest | 31.23% |
Days to Cover | 17.9 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Arcturus Therapeutics (NASDAQ:ARCT) through any online brokerage.
Other companies in Arcturus Therapeutics’s space includes: Humacyte (NASDAQ:HUMA), Valneva (NASDAQ:VALN), Celcuity (NASDAQ:CELC), Altimmune (NASDAQ:ALT) and Sage Therapeutics (NASDAQ:SAGE).
Arcturus Therapeutics has a consensus price target of $50.18.
The stock price for Arcturus Therapeutics (NASDAQ: ARCT) is $20.61 last updated September 20, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Arcturus Therapeutics.
Arcturus Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Arcturus Therapeutics.
Arcturus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.